Subscribe
Israel-Hamas Conflict
US Economy
Federal Reserve
Donald Trump
US Politics
US Immigration
Republican Party
Volleyball
Kamala Harris
Soccer
Immigration
Senate
Sean 'Diddy' Combs
Published

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

  • Nearly 2,000 drug manufacturing plants have not been inspected since the COVID-19 pandemic began, according to an investigation by The Associated Press .
  • Over 340 overdue plants are located in India and China, which are key sources of drug ingredients for U.S. Prescriptions.
  • The FDA has experienced staff shortages, contributing to the backlog of uninspected plants, as noted by Rogers.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Associated Press NewsAssociated Press News

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19.

·United States
Read Full Article
abc Newsabc News

5 takeaways from AP's report on the big backlog of uninspected drug factories

Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants

·United States
Read Full Article
NewsweekNewsweek

COVID delays leave nearly 2,000 drug plants behind on inspections: report

The FDA has been backlogged in drug factory inspections since before the COVID-19 pandemic, a new report found.

·United States
Read Full Article
The Toronto StarThe Toronto Star

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic

·Toronto, Canada
Read Full Article
Flin Flon ReminderFlin Flon Reminder

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U.S.

·Flin Flon, Canada
Read Full Article
Rocky Mountain OutlookRocky Mountain Outlook

Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds

WASHINGTON (AP) — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U.S.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 54% of the sources lean Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

FDAFDA
PoliticsPolitics
US PoliticsUS Politics
HealthHealth
CoronavirusCoronavirus
MedicalMedical
PandemicPandemic
Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal